nach oben

European Journal of Nuclear Medicine and Molecular Imaging

Erschienen in:

01.08.2008 | Image of the Month

Whole body 18fluoro-l-dopa PET–CT: a useful tool for location and surgical guidance in primary carcinoid tumours

verfasst von: J. Arbizu, M. Rodriguez-Fraile, I. Dominguez-Prado, P. Garrastachu, F. Rotellar, B. Sangro, J. A. Richter

Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging | Ausgabe 8/2008

Einloggen, um Zugang zu erhalten

Excerpt

Neuroendocrine tumours (NETs) represent a diagnostic and therapeutic challenge. Primary tumour is not localised in 20% to 50% of NETs, midgut carcinoids being particularly elusive [1]. 18Fluoro-l-dopa has emerged as a new imaging tool for NETs diagnosis with improved tumour detection and staging compared with conventional imaging (SRS and/or CT) [2, 3]. We present a patient with metastatic carcinoid tumour who underwent PET–CT scan with 18fluoro-l-dopa, which was of key importance to locate the primary tumour and guide its surgical resection. …

Modlin IM, Oberg K, Chung DC, Jensen RT, de Herder WW, Thakker RV, et al. Gastroenteropancreatic neuroendocrine tumours. Lancet Oncol 2008;9:61–72.PubMedCrossRef

Koopmans KP, de Vries EG, Kema IP, Elsinga PH, Neels OC, Sluiter WJ, et al. Staging of carcinoid tumours with 18F-DOPA PET: a prospective, diagnostic accuracy study. Lancet Oncol 2006;7:728–34.PubMedCrossRef

Ambrosini V, Tomassetti P, Rubello D, Campana D, Nanni C, Castellucci P, et al. Role of 18F-dopa PET/CT imaging in the management of patients with 111In-pentetreotide negative GEP tumours. Nucl Med Commun 2007;28:473–7.PubMedCrossRef

Pearse AG. The APUD cell concept and its implications in pathology. Pathol Annu 1974;9:27–41.PubMed

Titel: Whole body 18fluoro-l-dopa PET–CT: a useful tool for location and surgical guidance in primary carcinoid tumours
verfasst von: J. Arbizu
M. Rodriguez-Fraile
I. Dominguez-Prado
P. Garrastachu
F. Rotellar
B. Sangro
J. A. Richter
Publikationsdatum: 01.08.2008
Verlag: Springer-Verlag
Erschienen in: European Journal of Nuclear Medicine and Molecular Imaging / Ausgabe 8/2008
Print ISSN: 1619-7070
Elektronische ISSN: 1619-7089
DOI: https://doi.org/10.1007/s00259-008-0801-6

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 8/2008

[18F]Fluorinated estradiol derivatives for oestrogen receptor imaging: impact of substituents, formulation and specific activity on the biodistribution in breast tumour-bearing mice

Evaluation of biodistribution and anti-tumor effect of a dimeric RGD peptide–paclitaxel conjugate in mice with breast cancer

Prostate biopsy guided by 18F-fluorocholine PET in men with persistently elevated PSA levels

FDG avidity and PET/CT patterns in primary gastric lymphoma

Effects of AV delay programming on ventricular resynchronisation: role of radionuclide ventriculography

TENTH ANNIVERSARY OF THE DEPARTMENT OF NUCLEAR MEDICINE OF THE CLINIQUE STE THÉRÈSE IN LUXEMBOURG